chr19-49830790-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_030973.4(MED25):​c.1004C>T​(p.Ala335Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00665 in 1,613,014 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0043 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 41 hom. )

Consequence

MED25
NM_030973.4 missense

Scores

1
1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:10O:1

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
MED25 (HGNC:28845): (mediator complex subunit 25) This gene encodes a component of the transcriptional coactivator complex termed the Mediator complex. This complex is required for transcription of most RNA polymerase II-dependent genes. The encoded protein plays a role in chromatin modification and in preinitiation complex assembly. Mutations in this gene are associated with Charcot-Marie-Tooth disease type 2B2. [provided by RefSeq, Apr 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015774012).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00428 (651/152228) while in subpopulation NFE AF= 0.00725 (493/67998). AF 95% confidence interval is 0.00672. There are 3 homozygotes in gnomad4. There are 294 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MED25NM_030973.4 linkuse as main transcriptc.1004C>T p.Ala335Val missense_variant 9/18 ENST00000312865.10 NP_112235.2
MED25NM_001378355.1 linkuse as main transcriptc.1004C>T p.Ala335Val missense_variant 9/18 NP_001365284.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MED25ENST00000312865.10 linkuse as main transcriptc.1004C>T p.Ala335Val missense_variant 9/181 NM_030973.4 ENSP00000326767 Q71SY5-1
MED25ENST00000538643.5 linkuse as main transcriptc.365C>T p.Ala122Val missense_variant 4/131 ENSP00000437496 Q71SY5-6
MED25ENST00000595185.5 linkuse as main transcriptc.688+842C>T intron_variant 1 ENSP00000470027
MED25ENST00000593767.3 linkuse as main transcriptc.1004C>T p.Ala335Val missense_variant 9/183 ENSP00000470692 P1

Frequencies

GnomAD3 genomes
AF:
0.00427
AC:
650
AN:
152110
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000624
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00725
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00384
AC:
952
AN:
247818
Hom.:
3
AF XY:
0.00384
AC XY:
517
AN XY:
134684
show subpopulations
Gnomad AFR exome
AF:
0.00115
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.00131
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000753
Gnomad FIN exome
AF:
0.00372
Gnomad NFE exome
AF:
0.00674
Gnomad OTH exome
AF:
0.00429
GnomAD4 exome
AF:
0.00690
AC:
10082
AN:
1460786
Hom.:
41
Cov.:
33
AF XY:
0.00672
AC XY:
4886
AN XY:
726696
show subpopulations
Gnomad4 AFR exome
AF:
0.000867
Gnomad4 AMR exome
AF:
0.00114
Gnomad4 ASJ exome
AF:
0.00119
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000673
Gnomad4 FIN exome
AF:
0.00427
Gnomad4 NFE exome
AF:
0.00836
Gnomad4 OTH exome
AF:
0.00644
GnomAD4 genome
AF:
0.00428
AC:
651
AN:
152228
Hom.:
3
Cov.:
32
AF XY:
0.00395
AC XY:
294
AN XY:
74424
show subpopulations
Gnomad4 AFR
AF:
0.00156
Gnomad4 AMR
AF:
0.00333
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.000833
Gnomad4 FIN
AF:
0.00264
Gnomad4 NFE
AF:
0.00725
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00610
Hom.:
6
Bravo
AF:
0.00413
TwinsUK
AF:
0.00917
AC:
34
ALSPAC
AF:
0.00804
AC:
31
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.00364
AC:
442
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00605
EpiControl
AF:
0.00575

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:10Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 15, 2018- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024MED25: BS2 -
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Charcot-Marie-Tooth disease type 2B2 Uncertain:1Other:1
Uncertain significance, no assertion criteria providedliterature onlyOMIMOct 01, 2009- -
not provided, no classification providedliterature onlyClinVar Staff, National Center for Biotechnology Information (NCBI)-- -
Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome Benign:2
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 06, 2023- -
Likely benign, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterJan 01, 2019- -
Tip-toe gait Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingPractice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice Pomarino-Hereditary motor sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth Disease (CMT), is the most commonly inherited peripheral polyneuropathy. It constitutes a group of inherited, progressive, motor and sensory peripheral nerve disorders with properties of demyelination, axonal degeneration, or both. It is classified by clinical characteristics, modes of inheritance, electrophysiologic features, metabolic defects, and specific gene markers. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 14, 2020- -
Charcot-Marie-Tooth disease Benign:1
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Charcot-Marie-Tooth disease type 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
MED25-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 15, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
20
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.22
.;T;.;.
Eigen
Benign
-0.12
Eigen_PC
Benign
0.094
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.74
T;T;T;.
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.016
T;T;T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.55
.;N;.;.
MutationTaster
Benign
0.10
A;A
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
0.010
.;N;N;.
REVEL
Benign
0.29
Sift
Benign
0.17
.;T;T;.
Sift4G
Benign
0.25
T;T;T;T
Polyphen
0.021
.;B;.;.
Vest4
0.48
MVP
0.64
MPC
0.52
ClinPred
0.0077
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.050
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145770066; hg19: chr19-50334047; API